Correlation of Cytokine Release Syndrome With Prognosis After Chimeric Antigen Receptor T Cell Therapy: Analysis of 54 Patients With Relapsed or Refractory Multiple Myeloma

Correlation of Cytokine Release Syndrome With Prognosis After Chimeric Antigen Receptor T Cell Therapy: Analysis of 54 Patients With Relapsed or Refractory Multiple Myeloma

Although chimeric antigen receptor T (CAR-T) cell therapy has proven to be effective in treating relapsed or refractory multiple myeloma (R/R MM), the severity of cytokine release syndrome (CRS) can affect patient survival and the risk factors for CRS remain an intractable issue. We enrolled 54 pati...

Full description

Bibliographic Details
Main Authors: Xue Wang, Lina Zhao, Jing Wang, Yue Yao, Jiaojiao Wang, Shengwei Ji, Tian Hua, Shiyuan Wang, Hai Cheng, Ming Shi, Zhenyu Li, Lingyu Zeng, Junnian Zheng, Kailin Xu, Jiang Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Immunology
Subjects:
multiple myeloma
cytokine release syndrome
chimeric antigen receptor T cell
CD19
B cell maturation antigen
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.814548/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.814548/full

Similar Items